Unibios Holdings (ATH:BIOSK) Issuance of Debt: €1.62 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATH:BIOSK Unibios Holdings SA ATH:BIOSK
67 GF Score
Price €2.72
GF Value €1.48
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Unibios Holdings Issuance of Debt?

Unibios Holdings ATH:BIOSK +6.04% 67 Issuance of Debt is €1.62 Mil as of Dec. 2025. GuruFocus rates ATH:BIOSK with a GF Score™ of 67/100 and a GF Value™ of €1.48 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Unibios Holdings's Issuance of Debt for the six months ended in Dec. 2025 was €1.62 Mil.

Unibios Holdings's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was €1.62 Mil.

Unibios Holdings Issuance of Debt Related Terms

Unibios Holdings Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Unibios Holdings's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unibios Holdings Issuance of Debt Chart

Unibios Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 101.65 2.49 1.25 0.92 1.32

Unibios Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 2.69 0.00 1.62
ATH:BIOSK
67GF Score
Unibios Holdings SA ATH:BIOSK
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unibios Holdings Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of €1.62 Mil mean?
Unibios Holdings (ATH:BIOSK) has a Issuance of Debt of €1.62 Mil as of Dec. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Unibios Holdings and its competitors.
Is Unibios Holdings' Issuance of Debt too high?
Unibios Holdings' current Issuance of Debt is €1.62 Mil. Overall, Unibios Holdings has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Unibios Holdings' Issuance of Debt compare to VLTO and ZWS?
Unibios Holdings' Issuance of Debt of €1.62 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for an Industrial Products company?
A good Issuance of Debt depends on the Industrial Products industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Unibios Holdings and its competitors. Unibios Holdings's current Issuance of Debt is €1.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unibios Holdings stock overvalued right now?
Based on GuruFocus' analysis, Unibios Holdings (ATH:BIOSK) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.48, compared to a current price of €2.72 — trading 83.8% above its estimated fair value. The current Issuance of Debt is €1.62 Mil. Unibios Holdings' overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Unibios Holdings (ATH:BIOSK), the current Issuance of Debt is €1.62 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unibios Holdings (ATH:BIOSK) Overvalued in 2026?

Based on GuruFocus' analysis, Unibios Holdings stock appears to be overvalued. The current stock price of €2.72 is trading 83.8% above its estimated GF Value™ of €1.48. GuruFocus considers Unibios Holdings to be Significantly Overvalued.

Key valuation signals for ATH:BIOSK:

  • Issuance of Debt: €1.62 Mil
  • GF Value™: €1.48 vs. price of €2.72 (83.8% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the ATH:BIOSK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unibios Holdings Business Description

Other Exchanges BEXQ:Germany
Address 1st and 18th Street, Ano Liosia, GRC, 13341
Unibios Holdings SA, through its subsidiaries, provides technologies for the responsible use of water and energy. Its activities include the treatment, filtration, water management, heating, and air conditioning, combined with energy saving.
67GF Score

Get the complete analysis for ATH:BIOSK

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.72
Price
€1.48
GF Value